Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
financing
5
×
life sciences
national blog main
startups
5
×
venture capital
boston blog main
funding
san diego blog main
san diego top stories
vc
boston
boston top stories
cancer
laura shawver
national top stories
san diego
san francisco blog main
20/20 healthcare partners
accent therapeutics
aducanumab
akero therapeutics
alnylam
alzheimer's disease
amblyotech
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
apellis pharmaceuticals
aragon pharmaceuticals
arena pharmaceuticals
artie suckow
asklepios biopharmaceutical
avalon ventures
bioeurope
biogen
biomarin pharmaceutical
boulder/denver blog main
boulder/denver top stories
brainvectis
What
new
5
×
drugs
advance
diseases
medicines
raises
activity
approach
approvals
associated
bags
bio
biogen
biologic
biologics
biology
biotechs
capital
clamped
companies
considered
covid
cytokine
delays
deliver
demonstrating
develop
developing
device
dialysis
diego’s
disease
drug
dtx
economic
enclear
enhanced
fast
fda
harmful
Language
unset
Current search:
financing
×
new
×
startups
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
